Newsroom-Katalog
| Zeit | Boehringer Ingelheim: Meldungen vom 28.04.2009 |
|---|---|
| 08:04 | No Increased Risk of Treatment-Induced Augmentation in Restless Legs Syndrome (RLS) Demonstrated in Long-Term Placebo-Controlled Study With Mirapexin(R) / Sifrol(R) (Pramipexole) |